Skip to main content
Premium Trial:

Request an Annual Quote

Becton Dickinson May Collaborate with Accelr8 on Rapid Dx Platform

NEW YORK (GenomeWeb News) – Becton Dickinson has bought the rights to negotiate with Accelr8 Technology to develop its BACcel rapid diagnostic platform, Accelr8 said Thursday.
BD will pay Accelr8 $100,000 for the right to an exclusive negotiation period lasting through March 31, 2008, during which the companies will consider a development and commercialization program for the system. Such an agreement could include licensing rights, an equity investment, a joint development, or other type of development program, said Accelr8.
“BD could bring many resources to bear and speed the path to market, helping to further consolidate their leadership in managing infectious diseases,” Accelr8 President David Howson said in a statement.
Accelr8 believes the system can be used to target hospital-acquired infections and antibiotic-resistant pathogens including methicillin-resistant Staphylococcus aureus, Acinetobacter, Pseudomonas, and other strains of Klebsiella and E. coli.
The hospital-acquired infections testing market is a key target for BD, which acquired HAI molecular diagnostics developer GeneOhm Sciences nearly two years ago for $230 million.
Howson also noted that the BACcel complements BD’s automated culturing systems and gene analysis offerings.
In mid-afternoon trade on the American Stock Exchange, Accelr8’s shares were up 16 percent at $4.8050.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.